investorscraft@gmail.com

Intrinsic Value of Celldex Therapeutics, Inc. (CLDX)

Previous Close$37.75
Intrinsic Value
Upside potential
Previous Close
$37.75

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %-49.3NaN
Revenue, $2NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m118NaN
Operating income, $m-115NaN
EBITDA, $m-111NaN
Interest expense (income), $mNaN
Earnings before tax, $m-112NaN
Tax expense, $m0NaN
Net income, $m-112NaN

BALANCE SHEET

Cash and short-term investments, $m305NaN
Total assets, $m353NaN
Adjusted assets (=assets-cash), $m48NaN
Average production assets, $m31NaN
Working capital, $m299NaN
Total debt, $m4NaN
Total liabilities, $m27NaN
Total equity, $m326NaN
Debt-to-equity ratio0.012NaN
Adjusted equity ratio0.475NaN

CASH FLOW

Net income, $m-112NaN
Depreciation, amort., depletion, $m4NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-104NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-2NaN
Free cash flow, $m-102NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m299
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount